PRESTIGE BIOPHARMA LIMITED

🇸🇬Singapore
Ownership
-
Employees
-
Market Cap
-
Website
einpresswire.com
·

Key Trastuzumab Biosimilars Market Trend 2024-2033: Focus on New Product Launches

Trastuzumab biosimilars market to grow from $4.27B in 2023 to $5.43B in 2024, reaching $14.69B by 2028, driven by market expansion, patent expirations, and competitive pricing.
© Copyright 2024. All Rights Reserved by MedPath